Wednesday, January 13, 2016 7:29:48 PM
If one has studied TA charting for years then they can see the complexity of the technical charts Ive been doing, but hopefully, I can show it without too much confusion or making it messy
Sometimes its easy to get lost in all the target points ,all the data, all the lines and s/r levels, you can draw a chart using 10 tools and then it starts to look too messy to see anything.
Over the past few years of study Ive taken a liking to a few TA tools that when used in combination together, they show a picture that is both complex and clear to my eyes.
There is any number of tools that chartists can use in combination, and if you find the right ones that help your vision then most folks seem to stay with what works for them. I know a few traders I talk with who use a different tool set combination, and that works ok for them.
Sometimes, I just play the odds and make buys and sells based mostly on Technical target points, and its a judgement based on the numbers and the TA. and many times that works just fine. But my last buy did not work so well. ...
watching all the price action playing out last few weeks, I decided that the downwave last week was making a buy trigger for my technical trading on the day it fell to 5.05 and bounced..... the stair step just above that at 5.20 , 8 minutes earlier, was where I pulled the trigger and bought a few more shares at 5.20.
It represented the shares I wanted at the 5 dollar zone.
My next buy after that was the 3.77 bottom....oops....former bottom... ....and then after that I planned on selling some shares in the 5.60-6.00 area when price bounced there and Fails to continue higher.........BUT what happened,was a single "blink and you miss it" pop to 5.80 at the open monday.....and I wasnt quick enough to make the decision.as this latest downwave plunge really didnt give us much of any chance.
Now it looks like we are watching this shorting attack play out once again, and all I can do is decide what price I want to buy more. the 3.77 point was ok. as was 3.50 today....and anywhere in between...
But I dont think anyone can proclaim that this 3.50 Bottom is the bottom. just as last weeks 3.77 looked ok.
So here's another Fibonacci chart pictures I look at and they show the mathematic targets in the zone from 2.77 to 3.77. they show the topping zone and Ichimoku cloud area that runs from 5.50 area to 8 dollars. You can see the rolling over shape of the channel. There are many places from where to begin drawing the Fib Arc, and there is an art to it, to find the way the tools frame the price points. I'm trying to sharpen my vision by using the tools in this way.
Its both educated guesswork,and Intuitive feeling,using alot of complex data that sees as many points as possible. That technical buy at 5.20 ,I call a mistake now. and I want to fix that and improve some more.
At any point now ,in this 'bottom zone' price can hold this support low, or the last support low, or the next support low, any of them could hold,in this bottom zone that I'm seeing as 2.80-3.80...a big Bottom Zone.
I expect I will buy more at some point in this zone. and I'll need to trim excess shares in the next Resistance topping target zone when the time comes.
Theres a low pivot point around 2.64 now. in case it means anything.
Recent AVXL News
- Anavex’s Blarcamesine Achieves Pre-specified Efficacy in Phase IIb/III Alzheimer’s Trial: Data Presented at CTAD Conference 2024 • GlobeNewswire Inc. • 10/31/2024 08:00:00 AM
- ZenaTech, Inc. (NASDAQ: ZENA) Software Company Acquisition • InvestorsHub NewsWire • 10/23/2024 12:03:31 PM
- Anavex Life Sciences Announces Encouraging Preliminary Biomarker Results from Ongoing Phase 2 Study of ANAVEX®3-71 for the Treatment of Schizophrenia • GlobeNewswire Inc. • 10/17/2024 11:30:00 AM
- ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • InvestorsHub NewsWire • 10/15/2024 12:21:48 PM
- ZenaTech, Inc. (NASDAQ: ZENA) To Commence Trading Today • InvestorsHub NewsWire • 10/01/2024 11:00:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 26th Annual Global Investment Conference 2024 • GlobeNewswire Inc. • 09/03/2024 11:30:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/06/2024 09:21:05 PM
- Anavex Life Sciences Reports Fiscal 2024 Third Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 08/06/2024 11:30:00 AM
- Anavex Life Sciences to Announce Fiscal 2024 Third Quarter Financial Results on Tuesday, August 6, 2024 • GlobeNewswire Inc. • 08/01/2024 11:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/30/2024 09:20:53 PM
- Anavex Life Sciences Announces Translational Biomarker Data for ANAVEX®2-73 (blarcamesine) in Fragile X Syndrome (Major Cause of Autism) at the 19th NFXF International Fragile X Conference • GlobeNewswire Inc. • 07/30/2024 11:30:00 AM
- Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 07/29/2024 09:21:49 PM
- Results from Anavex Life Sciences Landmark Phase IIb/III Trial of Blarcamesine Presented at Alzheimer's Association Conference • GlobeNewswire Inc. • 07/28/2024 09:00:00 PM
- Anavex Life Sciences to Present at the H.C. Wainwright 5th Annual Neuro Perspectives Virtual Conference • GlobeNewswire Inc. • 06/20/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/17/2024 11:30:10 AM
- Anavex Life Sciences Announces Expansion of Leadership Team • GlobeNewswire Inc. • 05/22/2024 11:30:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/17/2024 10:01:00 AM
- Anavex Life Sciences to Present at the H.C. Wainwright 2nd BioConnect Investor Conference at NASDAQ • GlobeNewswire Inc. • 05/14/2024 11:30:00 AM
- Shareholders that lost money on Anavex Life Sciences Corporation(AVXL) Urged to Join Class Action - Contact The Gross Law Firm to Learn More • PR Newswire (US) • 05/10/2024 09:45:00 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/09/2024 08:35:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/09/2024 12:00:30 PM
- Anavex Life Sciences Reports Fiscal 2024 Second Quarter Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- The Gross Law Firm Announces the Filing of a Securities Class Action on Behalf of Anavex Life Sciences Corporation(AVXL) Shareholders • PR Newswire (US) • 05/07/2024 09:45:00 AM
- Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 05/06/2024 10:03:33 AM
Oohvie App Update Enhances Women's Health with Telemedicine and Online Scheduling • HLYK • Nov 11, 2024 8:00 AM
SANUWAVE Announces Record Quarterly Revenues: Q3 FY2024 Financial Results • SNWV • Nov 8, 2024 7:07 AM
DBG Pays Off $1.3 Million in Convertible Notes, which Retires All of the Company's Convertible Notes • DBGI • Nov 7, 2024 2:16 PM
SMX and FinGo Enter Into Collaboration Mandate to Develop a Joint 'Physical to Digital' Platform Service • SMX • Nov 7, 2024 8:48 AM
Rainmaker Worldwide Inc. (OTC: RAKR) Announces Successful Implementation of 1.6 Million Liter Per Day Wastewater Treatment Project in Iraq • RAKR • Nov 7, 2024 8:30 AM
SBC Medical Group Holdings and MEDIROM Healthcare Technologies Announce Business Alliance • SBC • Nov 7, 2024 7:00 AM